Vital Chemtech confirms no encumbrance over shares in FY26

0 min read     Updated on 04 Jun 2026, 02:49 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Vipul Bhatt, promoter of Vital Chemtech Limited, declared no new encumbrance over shares held by the promoter group during FY26. The declaration was submitted to the National Stock Exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

powered bylight_fuzz_icon
42067147

*this image is generated using AI for illustrative purposes only.

Vipul Bhatt, promoter of Vital Chemtech Limited , has confirmed that no new encumbrance was created over the shares held by the promoter group during the financial year 2025-26. The declaration was submitted to the National Stock Exchange in compliance with regulatory requirements.

The filing was made under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. Bhatt stated that none of the promoters, the Promoter Group, or persons acting in concert have created any encumbrance over the shares of Vital Chemtech Limited, other than those already disclosed, directly or indirectly.

The confirmation covers the entire financial year 2025-26. The declaration is addressed to the Audit Committee of Vital Chemtech Limited and was submitted to the exchanges on April 01, 2016.

Key Details of the Filing

Aspect Details
Regulation Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011
Declarant Vipul Bhatt, Promoter
Company Vital Chemtech Limited
Period Covered Financial Year 2025-26
Status No encumbrance other than already disclosed

Historical Stock Returns for Vital Chemtech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.05%+3.21%-6.56%-2.00%-13.86%-65.51%

How will the absence of new encumbrances impact investor confidence in Vital Chemtech's financial stability?

What are the potential implications for the company's future capital raising strategies?

Could this declaration signal a shift in the promoter's long-term commitment to the company?

Vital Chemtech FY26 profit falls 74.1% to ₹1 crore

1 min read     Updated on 02 Jun 2026, 02:12 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Vital Chemtech Limited announced its audited financial results for Q4FY26 and FY26, reporting a 74.1% YoY decline in PAT to ₹1.0 crore for the full year. Revenue for FY26 stood at ₹126.4 crore, a 5.6% decrease from the previous year, while Q4 revenue remained flat at ₹35.1 crore. The company improved Q4 EBITDA by 39.7% to ₹4.0 crore but noted that profitability was impacted by investments in subsidiaries Vital Synthesis Limited and Vital Alkoxides Private Limited.

powered bylight_fuzz_icon
41695689

*this image is generated using AI for illustrative purposes only.

Vital Chemtech Limited reported a 74.1% year-on-year decline in profit after tax (PAT) to ₹1.0 crore for the financial year ended March 31, 2026 (FY26), impacted by investments in its subsidiaries. Revenue from operations for FY26 decreased by 5.6% to ₹126.4 crore, compared to ₹133.9 crore in FY25. The company disclosed its audited standalone and consolidated financial results for Q4FY26 and FY26 on June 1, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

For the quarter ended March 31, 2026 (Q4FY26), revenue remained stable at ₹35.1 crore. EBITDA for the quarter rose 39.7% to ₹4.0 crore, with margins expanding by 320 basis points to 11.3%. However, Q4 PAT declined by 28.2% to ₹0.8 crore, with margins contracting by 95 basis points to 2.4%. The statutory auditors, M/s Abhishek Kumar & Associates, issued an unmodified opinion on the financial statements.

Financial Performance Summary

₹ crores unless otherwise mentioned Q4 FY26 Q4 FY25 YoY change (%) FY26 FY25 YoY change (%)
Revenue from operations 35.1 35.1 0.2% 126.4 133.9 -5.6%
EBITDA 4.0 2.8 39.7% 10.0 10.6 -5.6%
EBITDA Margin 11.3% 8.1% 320 bps 7.9% 7.9% 0 bps
Profit after tax 0.8 1.2 -28.2% 1.0 4.0 -74.1%
PAT Margin 2.4% 3.3% -95 bps 0.8% 3.0% -215 bps
EPS (₹) 0.4 0.5 -26.5% 0.4 1.7 -74.1%

Operational Highlights

The decline in profitability was primarily attributable to investments made in two subsidiaries, Vital Synthesis Limited and Vital Alkoxides Private Limited. Vital Synthesis Limited commenced commercial operations in Q3 FY26 and is witnessing a gradual scale-up in customer acceptance. Vital Alkoxides Private Limited delivered strong business momentum during FY26, achieving approximately 63% YoY revenue growth.

Vipul Bhatt, Chairman and Managing Director, stated that the company focused on strengthening its business foundation through strategic investments and operational improvements. He noted that while investments in subsidiaries impacted short-term profitability, they are expected to strengthen the group's growth platform and diversification strategy. The company operates a fully automated manufacturing complex at Dahej, Gujarat, with a cumulative installed capacity of 33,192 MT.

Historical Stock Returns for Vital Chemtech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.05%+3.21%-6.56%-2.00%-13.86%-65.51%

When does Vital Chemtech expect the investments in subsidiaries to translate into positive earnings?

What is the projected revenue contribution from Vital Synthesis Limited as customer acceptance scales up?

Will the company continue to prioritize expansion over profitability in the coming fiscal year?

More News on Vital Chemtech

1 Year Returns:-13.86%